Linical CoTSE:2183 -0.99%49 Median PS Value is 円637.29 as of Jun. 28, 2026, which is 100% below its 10-year median of 0.49. GuruFocus rates TSE:2183 with a GF Score™ of 49/100 and a GF Value™ of 円310.47 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 277 Biotechnology companies, Linical Co ranks better than 78.34% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Linical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円383.681. Linical Co's 10-Year median PS Ratio is 1.661. Therefore, the Median PS Value for today is 円637.29.
As of today (2026-06-28), Linical Co's share price is 円200.00. Linical Co's Median PS Value is 円637.29. Therefore, Linical Co's Price to Median PS Value for today is 0.31.
The historical rank and industry rank for Linical Co's Median PS Value or its related term are showing as below:
TSE:2183'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29 Med: 0.49 Max: 0.74
Current: 0.31
During the past 13 years, the highest Price to Median PS Value of Linical Co was 0.74. The lowest was 0.29. And the median was 0.49.
TSE:2183's Price-to-Median-PS-Value is ranked better than 78.34% of 277
companies
in the Biotechnology industry
Industry Median: 0.62
vs TSE:2183: 0.31
Linical Co (TSE:2183) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Linical Co's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
200.00
/
637.29
=
0.31
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linical Co Median PS Value Related Terms
Linical Co Median PS Value Historical Data
* Premium members only.
The historical data trend for Linical Co's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:2183 vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Linical Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Linical Co Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Linical Co's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Linical Co's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 1.661.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Linical Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円383.681.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Linical Co (TSE:2183) has a Median PS Value of 円637.29 as of Jun. 28, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Linical Co and its competitors. This is 129959% above median its historical median of 0.49. Over the past decade, Linical Co's Median PS Value has ranged from 0.29 to 0.74. According to the industry distribution chart, Linical Co ranks #60 out of 277 companies in the Biotechnology industry, placing it in the top 21.7%.
Is Linical Co's Median PS Value too high?
Linical Co's current Median PS Value of 円637.29 is 129959% above median its 10-year median of 0.49. Over the past 10 years, this metric has ranged from a low of 0.29 to a high of 0.74. Based on the distribution chart, Linical Co ranks #60 out of 277 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Linical Co has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Linical Co's Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Linical Co ranks #60 out of 277 companies for Median PS Value. This places Linical Co in the top 22% of its industry — outperforming the majority of peers. The industry median Median PS Value is 0.62. Historically, Linical Co's own Median PS Value has ranged from 0.29 to 0.74 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.62, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Linical Co and its competitors. For the Biotechnology industry, the median Median PS Value is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Linical Co's current Median PS Value is 円637.29, which is 129959% above median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Linical Co stock overvalued right now?
Based on GuruFocus' analysis, Linical Co (TSE:2183) is currently considered Possible Value Trap. The stock's GF Value™ is 円310.47, compared to a current price of 円200.00 — trading 35.6% below its estimated fair value. The current Median PS Value is 円637.29, which is 129959% above median its 10-year median of 0.49. Linical Co's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Linical Co (TSE:2183), the current Median PS Value is 円637.29 as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Linical Co (TSE:2183) Overvalued in 2026?
Based on GuruFocus' analysis, Linical Co stock appears to be undervalued.
The current stock price of 円200.00 is trading 35.6% below its estimated GF Value™ of 円310.47.
GuruFocus considers Linical Co to be Possible Value Trap.
Key valuation signals for TSE:2183:
Median PS Value: 円637.29 (129959% above median its 10-year median of 0.49)
GF Value™: 円310.47 vs. price of 円200.00 (35.6% below fair value)
No single metric tells the full story. See the TSE:2183 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:2183 has been successfully added to your 
